Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Xia Xiao and Xiaojing Dong.
Xia Xiao
Connection Strength
0.461
Xiaojing Dong
  1. Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2. Front Immunol. 2020; 11:586572.
    View in: PubMed
    Score: 0.229
  2. Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry. Sci China Life Sci. 2021 Aug 20.
    View in: PubMed
    Score: 0.060
  3. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation. Cell Mol Immunol. 2021 04; 18(4):945-953.
    View in: PubMed
    Score: 0.058
  4. Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase. Acta Pharm Sin B. 2021 Jun; 11(6):1555-1567.
    View in: PubMed
    Score: 0.058
  5. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020 07 30; 11(1):3810.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.